Skip To Main Content
Camille B Carroll on Muck Rack

Camille B Carroll

As seen in: Nature, Wiley Online Library, BMJ Open, Future Medicine, Research Protocols, NeurologyLive, ACNR Magazine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Camille B

Contact Camille B, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Ursodeoxycholic Acid and Parkinson's Disease Risk: An Emulated Target Trial in UK Electronic Health Records

|
By Chengsheng Ju, Anette Schrag, Camille B Carroll
| Wiley Online Library Verified
Filename Description mds70535-sup-0001-Supinfo.docxWord 2007 document , 1.3 MB Table S1. Specifications of the target pragmatic trial and observational trial emulation. Methods S1. Directed acyclic graph for covariate selection, and full list of covariates. Methods S2. Sequential trial emulation and risk estimation. Table S2. Diagnostic codes for ascertaining Parkinson's diseases. Table S3. Diagnostic codes for ascertaining hepatobiliary diseases. Methods S3.
Open in Who Shared Issue with article?

Slow-SPEED: protocol for three randomised trials of remotely delivered exercise to prevent Parkinson’s disease

|
By Thomas H. Oosterhof, Eleanor Mitchell, Alberto Ascherio, Stella Aslibekyan, Viktoria Azoidou, Kara Beasley, Yoav Ben-Shlomo, Eline M Bunnik, Camille B Carroll, Lana Chahine, Daniel Corcos, Jules M. Janssen Daalen, Karin van Dijk, Bauke W. Dijkstra, Lisanne J. Dommershuijsen, Ray Dorsey, Luc J. W. Evers, Rick C. Helmich, Martin Johansson, Lucy Norcliffe-Kaufmann, Jessi L. Keavney, Christine A. Klein, Matthew J Kmiecik, Thomas Kustermann, Eric Macklin, Kenneth Marek, Sanne K. Meles, Sebastiaan Overeem, Carl Philpott, Angelique Pijpers, Ronald B. Postuma, Helen Rowbotham, Sabine Schootemeijer, Michael A. Schwarzschild, Tanya Simuni, Michael Sommerauer, Ambra Stefani, Kenan Steidel, Marcel Verbeek, Nienke de Vries, Bart PC Van de Warrenburg, Richard K Wyse, Bastiaan R Bloem, Ruth Schneider, Alastair J. Noyce, Sirwan K. L. Darweesh, Rick van der Vliet
| Nature Verified
Abstract We describe the design of the first non-pharmacological Parkinson’s disease prevention trials worldwide: the randomised ‘Slow-SPEED’ trials. Three trials examine the feasibility and preliminary efficacy of a gamified, remotely administered exercise intervention vs. active control over 18–36 months in complementary prodromal subgroups: iRBD(n = 110; Netherlands), hyposmia(n = 110; United Kingdom) or LRRK2/GBA1 mutation carriers(n = 600; United States).
Open in Who Shared Issue with article?

The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process - Nature Reviews Neurology

|
By Harriet Demnitz-King, Claudia Cooper, Charlotte Kenten, Yvonne Birks, Carol Brayne, Camille B Carroll, Georgina Charlesworth, Carol Coupland, Tom Dening, Ruth Dobson, Sarah Foster, Gill Livingston, Magdalena Opazo Breton, Martin Orrell, Greta Rait, Jonathan M Schott, Alison Thomson, Dylan Williams, Charles R Marshall
| Nature Verified
Abstract Translation of evidence about dementia risk and its reduction into effective, equitable public health policy is a major challenge.
Open in Who Shared Issue with article?
See all 9 licensed articles (15 Total)